These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27774094)

  • 1. Human NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 Receptor.
    Pesce S; Moretta L; Moretta A; Marcenaro E
    Front Immunol; 2016; 7():414. PubMed ID: 27774094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bridging innate NK cell functions with adaptive immunity.
    Marcenaro E; Carlomagno S; Pesce S; Moretta A; Sivori S
    Adv Exp Med Biol; 2011; 780():45-55. PubMed ID: 21842364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of chemokines in the biology of natural killer cells.
    Maghazachi AA
    Curr Top Microbiol Immunol; 2010; 341():37-58. PubMed ID: 20369317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of chemokines in the biology of natural killer cells.
    Robertson MJ
    J Leukoc Biol; 2002 Feb; 71(2):173-83. PubMed ID: 11818437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue Distribution Dynamics of Human NK Cells Inferred from Peripheral Blood Depletion Kinetics after Sphingosine-1-Phosphate Receptor Blockade.
    Mehling M; Burgener AV; Brinkmann V; Bantug GR; Dimeloe S; Hoenger G; Kappos L; Hess C
    Scand J Immunol; 2015 Nov; 82(5):460-6. PubMed ID: 26285786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR7 ligands, SLC/6Ckine/Exodus2/TCA4 and CKbeta-11/MIP-3beta/ELC, are chemoattractants for CD56(+)CD16(-) NK cells and late stage lymphoid progenitors.
    Kim CH; Pelus LM; Appelbaum E; Johanson K; Anzai N; Broxmeyer HE
    Cell Immunol; 1999 May; 193(2):226-35. PubMed ID: 10222066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of CCL19 by DC-Lamp+ mature dendritic cells in human lymph node versus chronically inflamed skin.
    Katou F; Ohtani H; Nakayama T; Nagura H; Yoshie O; Motegi K
    J Pathol; 2003 Jan; 199(1):98-106. PubMed ID: 12474232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph.
    Carrega P; Bonaccorsi I; Di Carlo E; Morandi B; Paul P; Rizzello V; Cipollone G; Navarra G; Mingari MC; Moretta L; Ferlazzo G
    J Immunol; 2014 Apr; 192(8):3805-15. PubMed ID: 24646734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human NK Cell Subsets in Pregnancy and Disease: Toward a New Biological Complexity.
    Cristiani CM; Palella E; Sottile R; Tallerico R; Garofalo C; Carbone E
    Front Immunol; 2016; 7():656. PubMed ID: 28082990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of human natural killer cell migration and proliferation by the exodus subfamily of CC chemokines.
    Robertson MJ; Williams BT; Christopherson K; Brahmi Z; Hromas R
    Cell Immunol; 2000 Jan; 199(1):8-14. PubMed ID: 10675270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues.
    Ebert LM; Schaerli P; Moser B
    Mol Immunol; 2005 May; 42(7):799-809. PubMed ID: 15829268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging role of chemokine receptor 7 in atherosclerosis.
    Schieffer B; Luchtefeld M
    Trends Cardiovasc Med; 2011 Nov; 21(8):211-6. PubMed ID: 22902067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effector and regulatory events during natural killer-dendritic cell interactions.
    Moretta L; Ferlazzo G; Bottino C; Vitale M; Pende D; Mingari MC; Moretta A
    Immunol Rev; 2006 Dec; 214():219-28. PubMed ID: 17100887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human liver-resident CD56(bright)/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways.
    Hudspeth K; Donadon M; Cimino M; Pontarini E; Tentorio P; Preti M; Hong M; Bertoletti A; Bicciato S; Invernizzi P; Lugli E; Torzilli G; Gershwin ME; Mavilio D
    J Autoimmun; 2016 Jan; 66():40-50. PubMed ID: 26330348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Features of Memory-Like and PD-1(+) Human NK Cell Subsets.
    Della Chiesa M; Pesce S; Muccio L; Carlomagno S; Sivori S; Moretta A; Marcenaro E
    Front Immunol; 2016; 7():351. PubMed ID: 27683578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CCR7 and its ligands CCL19/CCL21 in muscles of polymyositis.
    Tateyama M; Fujihara K; Misu T; Feng J; Onodera Y; Itoyama Y
    J Neurol Sci; 2006 Nov; 249(2):158-65. PubMed ID: 16887149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene and protein characteristics reflect functional diversity of CD56dim and CD56bright NK cells.
    Wendt K; Wilk E; Buyny S; Buer J; Schmidt RE; Jacobs R
    J Leukoc Biol; 2006 Dec; 80(6):1529-41. PubMed ID: 16966385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: critical role in migration from the tumor site to draining lymph nodes.
    Hirao M; Onai N; Hiroishi K; Watkins SC; Matsushima K; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Apr; 60(8):2209-17. PubMed ID: 10786686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-18-based combinatorial adjuvants promote the intranodal production of CCL19 by NK cells and dendritic cells of cancer patients.
    Wong JL; Muthuswamy R; Bartlett DL; Kalinski P
    Oncoimmunology; 2013 Sep; 2(9):e26245. PubMed ID: 24228233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential upregulation of chemokine receptors on CD56 NK cells and their transmigration to the site of infection in tuberculous pleurisy.
    Pokkali S; Das SD; Selvaraj A
    FEMS Immunol Med Microbiol; 2009 Apr; 55(3):352-60. PubMed ID: 19159432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.